title_leftcircle.gif (666 bytes) Title
shim.gif (43 bytes) Home page Links Search Contact Us
shim.gif (43 bytes)
advances in bicarbonate peritoneal dialysis solutions
shim.gif (43 bytes)
Althea Mahon, Nurse Consultant PD, Barts and The London NHS Trust, describes the advantages of Physioneal TM and predicts that continuing work on such initiatives will improve both the quality of therapy and the quality of life for patients.
shim.gif (43 bytes)
 

For many years, lactate-containing peritoneal dialysis (PD) solutions have proved to be safe and effective, but they are not ideal.

To correct acidosis, the concentration of lactate in the dialysis solution needs to be in the range of 35-40mM, and the solution must be kept at low pH to prevent caramelisation of glucose during heat sterilisation (1). The combination of high lactate concentration and low pH can impair cellular function (2), and pain upon infusion during dialysis seems to be at least partly related to low pH (3).

Designing a PD solution

The ideal bio-compatible PD solution is one that does not affect the structure and function of the peritoneum. This can be achieved by using solutions that are identical in composition to that of the body's extracellular fluid: in particular, to the composition of blood.

A buffer in the body is a substance that keeps the pH of the extracellular fluids in the body around 7.4. Lactate buffer has most of its buffering capacity in a pH range of 3 to 5. The ideal buffer, however, is bicarbonate, since it is one of the few systems that acts both as a buffer in the body and as a solution buffer.

So, research into improved bio-compatible solutions has focused on two areas: a better, more bio-compatible osmotic agent; and a better pH and buffer.

An alternative to using lactate-containing buffer solutions is to use the natural buffer, bicarbonate. However, to correct acidosis, supranormal levels of bicarbonate would be needed, and the associated high pCO2 may have a detrimental effect on cell function and, in some instances, may be linked to infusion pain. There may also be an increased risk of calcium precipitation and peritoneal calcium deposition.

Developments in PD solutions

New developments in manufacturing technology have produced solutions such as Physioneal.

Physioneal™ is an innovative PD solution made up of a combination of bicarbonate (25mmol/L) and lactate (15mmol/L) as the buffer and can be used for all exchanges.
  Physioneal™ has a physiological pH of 7.4, and reduced glucose degradation product levels.
  It maintains a normal intraperitoneal pH whereas conventional lactate solutions need up to 120 minutes for the intraperitoneal pH to reach 7.4 or physiological level (4).
  It allows a significant reduction of inflow pain and/or discomfort in sensitive patients (5) and has a high potential for improved long-term preservation of the peritoneal membrane.

The bag itself is easy to use and comes as a two-chambered format. The top chamber contains a solution of dextrose, calcium chloride and magnesium chloride. The bottom chamber contains a solution of sodium bicarbonate, sodium lactate and sodium chloride. When the frangible seal between the chambers is broken, both solutions are mixed together and can then be infused into the patient.

Bicarbonate/lactate solutions have been shown to be effective in those patients in whom solutions based on lactate buffer only, with a low pH, cause abdominal pain or discomfort. The development of solutions such as Physioneal™ are a new way forward, and such innovative developments will continue to improve both the quality of therapy and the quality of life for patients.

shim.gif (43 bytes)
 
   
shim.gif (43 bytes)
 
articles in this section....
 
 How to help adolescents move from child to adult services
 
 Ageing patients pose a rewarding challenge
 
 Diabetics with CKD need combined care
 
 Peritoneal dialysis in the newborn
 
 Time to turn our attention to obesity
 
 Obesity is a matter of maths!
 
 Sessions teach importance of a healthy heart
 
 Understanding Icodextrin
 
 Advances in bicarbonate peritoneal dialysis solutions
 
 Renal drugs need regular review
 
 Lifelong dialysis challenges both patients and staff
 
 Nearly there with Renal NSF document
 
 Management guidelines in mild renal failure
 
 Managing the scourge of systemic vasculitis
 
 3rd Edition of The Renal Standards Document
 
 Ask patients if they use herbal medicines
 
 Cardiovascular disease in end-stage renal failure
 
 Make walking-sticks relics of the past
 
 Is Healthy Start Dialysis good for our patients?
   
 
References:
shim.gif (43 bytes)
1) Henderson IS, Couper IA, Lumsden A. (1986) Potentially irritant glucose metabolites in unused CAPD fluid. In: Maher JF, Winchester JF. (Editors). Frontiers in PD. 261-264. Field Rich and Associates, New York.
  2) Mackenzie, RK, Holmes, CJ, Moseley A, Jenkins JP, Williams JD, Coles GA et al. (1998) Bicarbonate/lactate and bicarbonate-buffered peritoneal dialysis fluids improve ex vivo peritoneal macrophage TNF a secretion. Journal of American Society of Nephrology. 9 1499-1506.
  3) Mactier RA, Sprosen TS, Gokal R, Williams PF, Lindbergh M, Malin RB et al. (1998) Bicarbonate and bicarbonate/lactate PD solutions for the treatment of infusion pain. Kidney International 53 1061-1067.
  4) Heimburger O, Waniewski J, Wang T, Widstam U, Lindholm B, Tranaeus A. (1998) Peritoneal transport with lactate 40mmol/Lvs. Bicarbonate/lactate 25/15 mmol/L dialysis fluids. J Amer Soc Nephrol 9 192A